HEAD INJURY CLINICAL AND LABORATORY RESEARCH CENTER
头部损伤临床和实验室研究中心
基本信息
- 批准号:3099399
- 负责人:
- 金额:$ 112.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1979
- 资助国家:美国
- 起止时间:1979-04-01 至 1989-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The main objective of this Head Injury Clinical and Laboratory Research
Center is to establish a system whereby rational and improved therapies for
patients with head injury can be defined, developed and tested
scientifically. To accomplish this objective, the proposed program will
(1) define the physiological, morphological, metabolic and psychosocial
sequelae of head injury in man; (2) collect, assemble, and analyze data
from head injured patients to formulate an accurate prognosis; (3) define
in a well controlled animal model the anatomical, physiological and
biochemical effects of injury on brain parenchyma and blood vessels and on
systemic function. The influence of systemic insults to the injured brain
will be studied both in man and in animal models. Evaluations will be made
in humans of therapy for brain acidosis, elevated intracranial pressure,
ischemic and hyperemic cerebral blood flows, neurophysiological status, and
post traumatic mental depression. The role of iatrogenic hypocapnic
alkalosis in the management of patients will be clarified.
The unifying hypothesis to be tested in that the brain parenchyma and its
intrinsic vasculature can sustain reversible injury. These tissue elements
can be rendered dysfunctional; yet, such dysfunction does not implicate
irreversible disruption. The dysfunctional state may be temporary and if
the internal milieu is appropriate for healing, the cells can recover.
Dysfunction may be represented by reduced, excessive or aberrant
metabolism. An animal intensive care unit and a controlled brain injury
model provide the experimental environment. Acute and chronic animal
studies will be conducted on morphologic neural and vascular changes, brain
glucose utilization, cerebral microcirculation, the brain arachidonic acid
cascade, regional cerebral blood flow and surface brain energy metabolism
following controlled brain injury. Therapy will be tested by studying
cerebral acidosis and treatment with THAM. We seek to understand the
fundamental basis of neuronal loss after injury, and, by intervention, to
reverse the process.
本研究的主要目的是进行颅脑损伤的临床和实验室研究,
中心的目标是建立一个系统,
可以定义、开发和测试头部受伤的患者,
科学地 为了实现这一目标,拟议方案将
(1)定义生理、形态、代谢和社会心理
人类头部损伤后遗症;(2)收集、整理和分析数据
从头部受伤的病人,以制定准确的预后;(3)定义
在良好控制的动物模型中,
损伤对脑实质和血管的生化影响,
系统功能 全身性损伤对脑损伤的影响
将在人类和动物模型中进行研究。 将进行评估
用于治疗脑酸中毒,颅内压升高,
缺血性和充血性脑血流量、神经生理状态,以及
创伤后精神抑郁 医源性低碳酸血症的作用
将澄清患者管理中的问题。
要检验的统一假设是,脑实质及其
内在脉管系统可维持可逆损伤。 这些组织成分
可能会出现功能障碍;然而,这种功能障碍并不意味着
不可逆转的破坏。 功能失调的状态可能是暂时的,如果
内部环境适合愈合,细胞可以恢复。
功能障碍可表现为减少、过度或异常
新陈代谢. 一个动物重症监护室和一个可控的脑损伤
模型提供了实验环境。 急性和慢性动物
将对形态学神经和血管变化、脑
葡萄糖利用,脑微循环,脑花生四烯酸
级联反应、局部脑血流量和表面脑能量代谢
在控制性脑损伤之后 治疗将通过研究
脑酸中毒和THAM治疗。 我们试图了解
损伤后神经元损失的基本基础,并通过干预,
逆转这个过程。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAROLD F YOUNG其他文献
HAROLD F YOUNG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAROLD F YOUNG', 18)}}的其他基金
IMPROVING OUTCOME IN SEVERE HEAD INJURY - PEG-SOD TRIAL
改善严重头部损伤的结果 - PEG-SOD 试验
- 批准号:
3416068 - 财政年份:1991
- 资助金额:
$ 112.23万 - 项目类别:
IMPROVING OUTCOME IN SEVERE HEAD INJURY - PEG-SOD TRIAL
改善严重头部损伤的结果 - PEG-SOD 试验
- 批准号:
3416067 - 财政年份:1991
- 资助金额:
$ 112.23万 - 项目类别:
INTRA-TUMOR ADOPTIVE IMMUNOTHERAPY FOR GLIOBLASTOMA
胶质母细胞瘤的肿瘤内过继免疫治疗
- 批准号:
3402317 - 财政年份:1985
- 资助金额:
$ 112.23万 - 项目类别:
INTRA-TUMOR ADOPTIVE IMMUNOTHERAPY FOR GLIOBLASTOMA
胶质母细胞瘤的肿瘤内过继免疫治疗
- 批准号:
3402320 - 财政年份:1985
- 资助金额:
$ 112.23万 - 项目类别: